ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Coagulation Factor IX Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-39N13140
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Coagulation Factor IX Market Research Report 2023
BUY CHAPTERS

Global Recombinant Coagulation Factor IX Market Research Report 2025

Code: QYRE-Auto-39N13140
Report
March 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Aptevo Bio Therapeutics
Takeda
CSL Behring
Rebinyn
Pfizer Inc

Recombinant Coagulation Factor IX Market

The global market for Recombinant Coagulation Factor IX was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Coagulation Factor IX, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Coagulation Factor IX.
The Recombinant Coagulation Factor IX market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Coagulation Factor IX market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Coagulation Factor IX manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Coagulation Factor IX Market Report

Report Metric Details
Report Name Recombinant Coagulation Factor IX Market
Segment by Type
  • 500 IU
  • 1000 IU
  • Other
Segment by Application
  • Adult
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Rebinyn, CSL Behring, Takeda, Sanofi, Aptevo Bio Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Coagulation Factor IX manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Coagulation Factor IX in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Coagulation Factor IX Market report?

Ans: The main players in the Recombinant Coagulation Factor IX Market are Pfizer, Rebinyn, CSL Behring, Takeda, Sanofi, Aptevo Bio Therapeutics

What are the Application segmentation covered in the Recombinant Coagulation Factor IX Market report?

Ans: The Applications covered in the Recombinant Coagulation Factor IX Market report are Adult, Children

What are the Type segmentation covered in the Recombinant Coagulation Factor IX Market report?

Ans: The Types covered in the Recombinant Coagulation Factor IX Market report are 500 IU, 1000 IU, Other

Recommended Reports

Coagulation Factors

Hemophilia & Therapy

Diagnostic Instruments

1 Recombinant Coagulation Factor IX Market Overview
1.1 Product Definition
1.2 Recombinant Coagulation Factor IX by Type
1.2.1 Global Recombinant Coagulation Factor IX Market Value Comparison by Type (2024 VS 2031)
1.2.2 500 IU
1.2.3 1000 IU
1.2.4 Other
1.3 Recombinant Coagulation Factor IX by Application
1.3.1 Global Recombinant Coagulation Factor IX Market Value by Application (2024 VS 2031)
1.3.2 Adult
1.3.3 Children
1.4 Global Recombinant Coagulation Factor IX Market Size Estimates and Forecasts
1.4.1 Global Recombinant Coagulation Factor IX Revenue 2020-2031
1.4.2 Global Recombinant Coagulation Factor IX Sales 2020-2031
1.4.3 Global Recombinant Coagulation Factor IX Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Coagulation Factor IX Market Competition by Manufacturers
2.1 Global Recombinant Coagulation Factor IX Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Coagulation Factor IX Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Coagulation Factor IX Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Coagulation Factor IX, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Coagulation Factor IX, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Coagulation Factor IX, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Coagulation Factor IX, Date of Enter into This Industry
2.8 Global Recombinant Coagulation Factor IX Market Competitive Situation and Trends
2.8.1 Global Recombinant Coagulation Factor IX Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Coagulation Factor IX Players Market Share by Revenue
2.8.3 Global Recombinant Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Coagulation Factor IX Market Scenario by Region
3.1 Global Recombinant Coagulation Factor IX Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Coagulation Factor IX Sales by Region: 2020-2031
3.2.1 Global Recombinant Coagulation Factor IX Sales by Region: 2020-2025
3.2.2 Global Recombinant Coagulation Factor IX Sales by Region: 2026-2031
3.3 Global Recombinant Coagulation Factor IX Revenue by Region: 2020-2031
3.3.1 Global Recombinant Coagulation Factor IX Revenue by Region: 2020-2025
3.3.2 Global Recombinant Coagulation Factor IX Revenue by Region: 2026-2031
3.4 North America Recombinant Coagulation Factor IX Market Facts & Figures by Country
3.4.1 North America Recombinant Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Coagulation Factor IX Sales by Country (2020-2031)
3.4.3 North America Recombinant Coagulation Factor IX Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Recombinant Coagulation Factor IX Market Facts & Figures by Country
3.5.1 Europe Recombinant Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Coagulation Factor IX Sales by Country (2020-2031)
3.5.3 Europe Recombinant Coagulation Factor IX Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Coagulation Factor IX Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Coagulation Factor IX Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Coagulation Factor IX Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Coagulation Factor IX Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Coagulation Factor IX Market Facts & Figures by Country
3.7.1 Latin America Recombinant Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Coagulation Factor IX Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Coagulation Factor IX Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Coagulation Factor IX Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Coagulation Factor IX Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Coagulation Factor IX Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Recombinant Coagulation Factor IX Sales by Type (2020-2031)
4.1.1 Global Recombinant Coagulation Factor IX Sales by Type (2020-2025)
4.1.2 Global Recombinant Coagulation Factor IX Sales by Type (2026-2031)
4.1.3 Global Recombinant Coagulation Factor IX Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Coagulation Factor IX Revenue by Type (2020-2031)
4.2.1 Global Recombinant Coagulation Factor IX Revenue by Type (2020-2025)
4.2.2 Global Recombinant Coagulation Factor IX Revenue by Type (2026-2031)
4.2.3 Global Recombinant Coagulation Factor IX Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Coagulation Factor IX Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Coagulation Factor IX Sales by Application (2020-2031)
5.1.1 Global Recombinant Coagulation Factor IX Sales by Application (2020-2025)
5.1.2 Global Recombinant Coagulation Factor IX Sales by Application (2026-2031)
5.1.3 Global Recombinant Coagulation Factor IX Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Coagulation Factor IX Revenue by Application (2020-2031)
5.2.1 Global Recombinant Coagulation Factor IX Revenue by Application (2020-2025)
5.2.2 Global Recombinant Coagulation Factor IX Revenue by Application (2026-2031)
5.2.3 Global Recombinant Coagulation Factor IX Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Coagulation Factor IX Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Recombinant Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Recombinant Coagulation Factor IX Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Rebinyn
6.2.1 Rebinyn Company Information
6.2.2 Rebinyn Description and Business Overview
6.2.3 Rebinyn Recombinant Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Rebinyn Recombinant Coagulation Factor IX Product Portfolio
6.2.5 Rebinyn Recent Developments/Updates
6.3 CSL Behring
6.3.1 CSL Behring Company Information
6.3.2 CSL Behring Description and Business Overview
6.3.3 CSL Behring Recombinant Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Behring Recombinant Coagulation Factor IX Product Portfolio
6.3.5 CSL Behring Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Company Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Recombinant Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takeda Recombinant Coagulation Factor IX Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Recombinant Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Recombinant Coagulation Factor IX Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Aptevo Bio Therapeutics
6.6.1 Aptevo Bio Therapeutics Company Information
6.6.2 Aptevo Bio Therapeutics Description and Business Overview
6.6.3 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product Portfolio
6.6.5 Aptevo Bio Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Coagulation Factor IX Industry Chain Analysis
7.2 Recombinant Coagulation Factor IX Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Coagulation Factor IX Production Mode & Process Analysis
7.4 Recombinant Coagulation Factor IX Sales and Marketing
7.4.1 Recombinant Coagulation Factor IX Sales Channels
7.4.2 Recombinant Coagulation Factor IX Distributors
7.5 Recombinant Coagulation Factor IX Customer Analysis
8 Recombinant Coagulation Factor IX Market Dynamics
8.1 Recombinant Coagulation Factor IX Industry Trends
8.2 Recombinant Coagulation Factor IX Market Drivers
8.3 Recombinant Coagulation Factor IX Market Challenges
8.4 Recombinant Coagulation Factor IX Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Aptevo Bio Therapeutics
Takeda
CSL Behring
Rebinyn
Pfizer Inc
List of Tables
 Table 1. Global Recombinant Coagulation Factor IX Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Coagulation Factor IX Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Coagulation Factor IX Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Coagulation Factor IX Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Coagulation Factor IX Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Coagulation Factor IX Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Coagulation Factor IX Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Coagulation Factor IX Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Coagulation Factor IX, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Coagulation Factor IX, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Coagulation Factor IX, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Coagulation Factor IX, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Coagulation Factor IX by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Coagulation Factor IX as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Coagulation Factor IX Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Coagulation Factor IX Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Coagulation Factor IX Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Coagulation Factor IX Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Coagulation Factor IX Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Coagulation Factor IX Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Coagulation Factor IX Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Coagulation Factor IX Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Coagulation Factor IX Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Coagulation Factor IX Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Coagulation Factor IX Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Coagulation Factor IX Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Coagulation Factor IX Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Coagulation Factor IX Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Coagulation Factor IX Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Coagulation Factor IX Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Coagulation Factor IX Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Coagulation Factor IX Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Coagulation Factor IX Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Coagulation Factor IX Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Coagulation Factor IX Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Coagulation Factor IX Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Coagulation Factor IX Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Coagulation Factor IX Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Coagulation Factor IX Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Coagulation Factor IX Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Coagulation Factor IX Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Coagulation Factor IX Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Coagulation Factor IX Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Coagulation Factor IX Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Coagulation Factor IX Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Coagulation Factor IX Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Coagulation Factor IX Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Coagulation Factor IX Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Coagulation Factor IX Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Coagulation Factor IX Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Coagulation Factor IX Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Coagulation Factor IX Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Coagulation Factor IX Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Coagulation Factor IX Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Coagulation Factor IX Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Coagulation Factor IX Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Recombinant Coagulation Factor IX Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Rebinyn Company Information
 Table 76. Rebinyn Description and Business Overview
 Table 77. Rebinyn Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Rebinyn Recombinant Coagulation Factor IX Product
 Table 79. Rebinyn Recent Developments/Updates
 Table 80. CSL Behring Company Information
 Table 81. CSL Behring Description and Business Overview
 Table 82. CSL Behring Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. CSL Behring Recombinant Coagulation Factor IX Product
 Table 84. CSL Behring Recent Developments/Updates
 Table 85. Takeda Company Information
 Table 86. Takeda Description and Business Overview
 Table 87. Takeda Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Takeda Recombinant Coagulation Factor IX Product
 Table 89. Takeda Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sanofi Recombinant Coagulation Factor IX Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. Aptevo Bio Therapeutics Company Information
 Table 96. Aptevo Bio Therapeutics Description and Business Overview
 Table 97. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product
 Table 99. Aptevo Bio Therapeutics Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Recombinant Coagulation Factor IX Distributors List
 Table 103. Recombinant Coagulation Factor IX Customers List
 Table 104. Recombinant Coagulation Factor IX Market Trends
 Table 105. Recombinant Coagulation Factor IX Market Drivers
 Table 106. Recombinant Coagulation Factor IX Market Challenges
 Table 107. Recombinant Coagulation Factor IX Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Coagulation Factor IX
 Figure 2. Global Recombinant Coagulation Factor IX Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Coagulation Factor IX Market Share by Type: 2024 & 2031
 Figure 4. 500 IU Product Picture
 Figure 5. 1000 IU Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Recombinant Coagulation Factor IX Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Recombinant Coagulation Factor IX Market Share by Application: 2024 & 2031
 Figure 9. Adult
 Figure 10. Children
 Figure 11. Global Recombinant Coagulation Factor IX Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Recombinant Coagulation Factor IX Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Recombinant Coagulation Factor IX Sales (2020-2031) & (K Units)
 Figure 14. Global Recombinant Coagulation Factor IX Average Price (US$/Unit) & (2020-2031)
 Figure 15. Recombinant Coagulation Factor IX Report Years Considered
 Figure 16. Recombinant Coagulation Factor IX Sales Share by Manufacturers in 2024
 Figure 17. Global Recombinant Coagulation Factor IX Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Recombinant Coagulation Factor IX Players: Market Share by Revenue in Recombinant Coagulation Factor IX in 2024
 Figure 19. Recombinant Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Recombinant Coagulation Factor IX Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Recombinant Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 22. North America Recombinant Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Recombinant Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 26. Europe Recombinant Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Recombinant Coagulation Factor IX Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Recombinant Coagulation Factor IX Revenue Market Share by Region (2020-2031)
 Figure 34. China Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Recombinant Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Recombinant Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Recombinant Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Recombinant Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Recombinant Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Recombinant Coagulation Factor IX by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Recombinant Coagulation Factor IX by Type (2020-2031)
 Figure 56. Global Recombinant Coagulation Factor IX Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Recombinant Coagulation Factor IX by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Recombinant Coagulation Factor IX by Application (2020-2031)
 Figure 59. Global Recombinant Coagulation Factor IX Price (US$/Unit) by Application (2020-2031)
 Figure 60. Recombinant Coagulation Factor IX Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Human Coagulation Factor IX Market Research Report 2024
Global Recombinant Human Coagulation Factor VIII for Injection Market Research Report 2024
Recombinant Coagulation Factor Ⅷ for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Factor Products Market Research Report 2024
Global Recombinant Factor C Assay Market Research Report 2024
Global Recombinant Growth Factors Market Research Report 2025
Global Human Recombinant Growth Factors Market Research Report 2025
Global Hemophilia Gene Therapy Market Research Report 2025
Global Topical Recombinant Thrombin Market Research Report 2024
Recombinant Cascade Reagent rCR and Recombinant Factor C Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemostatic Agents Market Research Report 2025
Global Coagulation Reagent Market Research Report 2025
Global Ready to Use Coagulase Plasma Market Research Report 2024
Global Factor IX Complex Market Research Report 2024
Coagulation Factor II Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Coagulation Factor IV Market Research Report 2024
Global Coagulants Market Research Report 2024
Global Recombinant Protein Reagents Market Research Report 2025
Global Recombinant Coagulation Factors Market Insights Forecast to 2030
Global Blood Clotting Aids Market Research Report 2025

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions